You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 11,649,217


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,649,217 protect, and when does it expire?

Patent 11,649,217 protects JESDUVROQ and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 11,649,217
Title:Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof
Abstract:The present disclosure relates to crystalline form CS1 and CS9 of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound (I) GSK1278863, processes for preparation, and uses for preparing drugs treating and/or preventing anemia thereof.
Inventor(s):Minhua Chen, Yanfeng Zhang, Jinqiu WANG, Xiaoyu Zhang
Assignee:GlaxoSmithKline Intellectual Property No 2 Ltd
Application Number:US17/174,006
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,649,217: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to understand its significance and implications. This article will provide a detailed analysis of United States Patent 11,649,217, focusing on its claims, the technology it covers, and its position within the patent landscape.

Patent Claims and Scope

Definition and Importance

Patent claims define the scope of protection granted to the patentee. They are the legal boundaries that distinguish the invention from prior art and other existing technologies[3].

Analyzing Patent Claims

To analyze the claims of U.S. Patent 11,649,217, one must first identify the type of patent (utility, design, or plant) and the specific claims made. Here are the key steps:

Claim Types

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Claim Structure

  • Claim Language: The language used in the claims is critical. It must be clear, concise, and specific to avoid ambiguity.
  • Claim Limitations: Each claim includes various limitations that define the invention's scope.

Example from the Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including their dependency relationships and statistical analyses. This dataset can be used to understand the trends and structures of patent claims, which can be applied to the analysis of U.S. Patent 11,649,217[3].

Technology Covered by the Patent

Overview of the Invention

U.S. Patent 11,649,217 would typically cover a specific technological innovation. Here, we need to identify what this innovation is and how it fits into the broader technological landscape.

Biotechnology and Molecular Sequences

For instance, if the patent pertains to biotechnology, it might involve prior-art searching of molecular sequences, similar to the Automated Biotechnology Sequence Search system (ABSS) used by the USPTO. This system searches electronic sequence listing data submitted by applicants and public/commercial databases of published sequence information[1].

Specialized Search Databases

The patent might rely on specialized search databases, such as those provided by the Patent Search System-Specialized Search (PSS-SS) at the USPTO. These databases are crucial for searching RNA/DNA sequences, chemical structures, and other complex technological data[1].

Patent Landscape and Prior Art

Understanding Prior Art

Prior art refers to any evidence that a particular invention or aspect of an invention was publicly known or used before the filing date of the patent application. Analyzing prior art is essential to determine the novelty and non-obviousness of the invention.

Inter Partes Reviews (IPRs)

Cases like Cytiva BioProcess R&D AB v. JSR Corp. illustrate the importance of prior art in determining patent validity. In this case, the Patent Trial and Appeal Board (PTAB) reviewed claims based on prior art and obviousness, highlighting the critical role of prior art in patent litigation[2].

Common Citation Document (CCD)

Tools like the Common Citation Document (CCD) consolidate prior art cited by multiple patent offices, facilitating a comprehensive search for prior art related to a patent application. This tool is particularly useful in international patent searches[4].

Access and User Interface

User Access

Identifying who has access to the information and systems related to the patent is crucial. For example, the PSS-SS system at the USPTO is accessed by various users, including patent examiners, applicants, and employees from the Scientific and Technical Information Center (STIC) and the Digital Resources Division[1].

Public Search Capabilities

The USPTO provides public search capabilities through its website, allowing anyone to search full-text patents and published applications. This accessibility is vital for transparency and for other inventors to understand the existing patent landscape[4].

Legal and Policy Considerations

Patent Litigation and Appeals

Patent litigation, such as the case of Cytiva BioProcess R&D AB v. JSR Corp., highlights the legal complexities surrounding patent claims. The Federal Circuit's review of PTAB decisions underscores the importance of substantial evidence and the legal standards applied in determining patent validity[2].

Small Claims Patent Court

There is ongoing discussion about the feasibility of a small claims patent court, which could impact how patent disputes are resolved, especially for smaller entities. This initiative, studied by the Administrative Conference of the United States (ACUS), aims to address the need for a more accessible and cost-effective patent dispute resolution process[5].

Key Takeaways

  • Patent Claims: The claims define the scope of protection and are crucial for distinguishing the invention from prior art.
  • Technology Covered: Understanding the specific technological innovation and its place in the broader landscape is essential.
  • Prior Art: Analyzing prior art is critical for determining novelty and non-obviousness.
  • Access and Interface: Identifying user access and public search capabilities is important for transparency and usability.
  • Legal Considerations: Patent litigation and policy initiatives, such as a small claims patent court, can significantly impact the patent landscape.

FAQs

What are the key components of a patent claim?

  • Independent claims, dependent claims, claim language, and claim limitations are the key components.

How does prior art impact patent validity?

  • Prior art can render a patent invalid if it shows that the invention was publicly known or used before the filing date.

What is the role of the USPTO's PSS-SS system?

  • The PSS-SS system provides specialized search databases for patent examiners and applicants, including searches for molecular sequences and chemical structures.

What is the Common Citation Document (CCD)?

  • The CCD consolidates prior art cited by multiple patent offices, facilitating comprehensive international patent searches.

Why is there a discussion about a small claims patent court?

  • The discussion aims to create a more accessible and cost-effective process for resolving patent disputes, particularly for smaller entities.

Sources

  1. U.S. Department of Commerce U.S. Patent and Trademark Office, "Privacy Threshold Analysis (PTA) for Patent Search System-Specialized Search (PSS-SS)".
  2. CYTIVA BIOPROCESS R&D AB v. JSR CORP., Federal Circuit Court of Appeals, December 4, 2024.
  3. USPTO, "Patent Claims Research Dataset".
  4. USPTO, "Search for patents".
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court".

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,649,217

Showing 1 to 5 of 5 entries

International Family Members for US Patent 11,649,217

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2018330994 ⤷  Try for Free
Canada 3112277 ⤷  Try for Free
China 111093668 ⤷  Try for Free
European Patent Office 3682884 ⤷  Try for Free
Japan 2020533396 ⤷  Try for Free
Spain 2980121 ⤷  Try for Free
World Intellectual Property Organization (WIPO) 2019052133 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.